Skip to main content
Log in

The hepatorenal syndrome

  • Review Articles
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, Rodes J (1981) Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Int Med 94:198

    Google Scholar 

  2. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodes J (1981) Effect of angiotensin II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 11:221

    Google Scholar 

  3. Arroyo V, Bosch J, Rivera F, Rodes J (1979) The renin angiotensin system in cirrhosis: its relation to functional renal failure. In: Bartoli E, Chiandussi L (eds) Hepatorenal syndrome, Piccin, Padova, p 202

    Google Scholar 

  4. Bartoli E, Chiandussi L (eds) (1979) Hepatorenal syndrome. Piccin, Padova, Italy

    Google Scholar 

  5. Bernardi M, Trevisani F, Santini C, Zoli G, Baraldini M, Ligabue A, Gasbarrini G (1983) Plasma norepinephrine, weak neurotransmitters and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology 3:56

    Google Scholar 

  6. Bichet DG, Grines BG, Schrier RW (1984) Effect of head out water immersion on hepatorenal syndrome. Am J Kidney Dis 3:258

    Google Scholar 

  7. Cobden I, Shore A, Wilkinson R, Record CO (1985) Captopril in the hepatorenal syndrome. J Clin Gastroenterol 7:354

    Google Scholar 

  8. Daskalopoulos G, Jordan DR, Reynolds TB (1985) Randomized trial of peritoneovenous shunt in the treatment of the hepatorenal syndrome. Gastroenterology 88:1655 (Abstract)

    Google Scholar 

  9. Epstein M (ed) (1983) The kidney in liver disease, 2nd edn. Elsevier, New York

    Google Scholar 

  10. Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, Merril JP (1970) Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 49:175

    Google Scholar 

  11. Green J, Beyar R, Bomzon L, Finberg JPM, Better OS (1984) Jaundice, the circulation and the kidney. Nephron 37:145

    Google Scholar 

  12. Helwig FC, Schutz CB (1932) A liver kidney syndrome: clinical, pathological and experimental studies. Surg Gynecol Obstet 55:570

    Google Scholar 

  13. Henriksen JH, Ring-Larsen H, Christensen NH (1984) Sympathetic nervous activity in cirrhosis: a survey of plasma catecholamine studies. J Hepatology 1:55

    Google Scholar 

  14. Hunt S, Vaamonde CA, Rattassi T, Berian G, Said SI, Papper S (1979) Circulating levels of vasoactive intestinal polypeptide in liver disease. Arch Intern Med 139:994

    Google Scholar 

  15. Iwatsuki S, Modecai M, Popovtzer MM, Corman JL, Ishikawa M, Putnam CW, Katz F, Starlz T (1973) Recovery from “Hepato-renal syndrome”, after orthotopic liver transplantation. N Engl J Med 289:1155

    Google Scholar 

  16. Kanel GC, Peters RL (1984) Glomerular tubular reflux: a morphologic renal lesion associated with the hepatorenal syndrome. Hepatology 4:242

    Google Scholar 

  17. Kew MD, Varma RR, Williams HS, Brunt PW, Houriga KJ, Sherlock S (1971) Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet 2:504

    Google Scholar 

  18. Kinney MJ, Schneider A, Wapnick S, Grosberg S, Le Veen H (1979) The hepatorenal syndrome and refractory ascites: successful therapy with the Le Veen type peritoneal-venous shunt and valve. Nephron 23:228

    Google Scholar 

  19. Kondo K, Nakamura R, Saito I, Saruta T, Matsuki S (1974) Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis. Jpn Circ J 38:913

    Google Scholar 

  20. Koppel MH, Coburb JW, Mims MM, Goldstein H, Boyle JD, Rubini ME (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. N Engl J Med 280:1367

    Google Scholar 

  21. Lancestremere RG, Klinger EL Jr, Frisch E, Papper S (1963) Simultaneous determination of cardiac output and renal function in patients with Laennec's cirrhosis during the administration of the pressor amine, metaraminol. J Lab Clin Med 61:820

    Google Scholar 

  22. Laragh JH (1985) Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 313:1330

    Google Scholar 

  23. Lieberman FL, Reynolds TB (1967) Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites and renal failure. J Clin Invest 46:1297

    Google Scholar 

  24. Mandel AK, Lansing M, Fahmy A (1982) Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am J Kidney Dis 2:363

    Google Scholar 

  25. Papper S (1980) Hepatorenal syndrome. Contrib Nephrol 23:55

    Google Scholar 

  26. Ring-Larsen H, Henriksen JH, Christensen NJH (1983) Increased sympathetic activity in cirrhosis. N Engl J Med 308:1029

    Google Scholar 

  27. Ring-Larsen H, Hesse B, Stigsby SC (1976) Effect of portalsystemic anastomosis on renal hemodynamics in cirrhosis. Gut 17:856

    Google Scholar 

  28. Saruta T, Toyohisa E, Saito I (1983) Angiotensin antagonists in liver disease. In: Epstein M (ed) The kidney in liver disease, 2nd edn. Elsevier, New York, p 441

    Google Scholar 

  29. Schroeder ET, Anderson GH Jr, Smulyan H (1979) Effects of portacaval or peritoneovenus shunt on renin in the hepatorenal syndrome. Kidney Int 15:54

    Google Scholar 

  30. Schroeder ET, Shear L, Sancetta SM, Gabuzda GJ (1967) Renal failure in patients with cirrhosis of the liver. III Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin. Am J Med 43:887

    Google Scholar 

  31. Tristani FE, Cohn JN (1967) Systemic and renal hemodynamics in oliguric hepatic failure. Effect of volume expansion. J Clin Invest 46:1894

    Google Scholar 

  32. Vaamonde CA, Papper S (1979) The kidney in liver disease. In: Early LE, Gottschalk CW (eds) Strauss and Welt's diseases of the kidney, 3rd edn. Little, Brown and Company, Boston, p 1289

    Google Scholar 

  33. Wilkinson SP, Moodie H, Stamatakid JP, Kakker VV, Williams R (1976) Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 2:1415

    Google Scholar 

  34. Wilkinson SP, Weston MJ, Parson V, Williams R (1977) Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8:287

    Google Scholar 

  35. Wilkinson SP, Williams R (1979) Defining “Hepatorenal syndrome”. In: Bartoli E, Chiandussi L (eds): Hepato renal syndrome, Piccin Medical Books, Padova, Italy, p 21

    Google Scholar 

  36. Wong PY, Talamo RC, William GH (1977) Kallikrein-kinin and renin-angiotensin system in functional renal failure of cirrhosis of the liver. Gastroenterology 73:1114

    Google Scholar 

  37. Zipser RD, Hoefs JC, Speckart PG, Zia PK, Horton R (1979) Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 48:895

    Google Scholar 

  38. Zipser RD, Kerlin P, Hoefs J, Zia PK, Barg A (1981) Urinary kallikrein excretion in cirrhosis: relationship to other vasoactive systems. Am J Gastroenterol 75:183

    Google Scholar 

  39. Zipser RD, Kronborg I, Rector W, Reynolds T, Daskalopoulos G (1984) Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Gastroenterology 87:1228

    Google Scholar 

  40. Zipser RD, Radvan GH, Kronborg I, Duke R, Little TE (1983) Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evikdence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 84:697

    Google Scholar 

  41. Zusman RM, Axelrod L, Tolkoff-Rubin N (1972) The treatment of the hepatorenal syndrome with intra-arterial administration of prostaglandin E2. Prostaglandins 13:819

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dr. Pinzani is a visiting scholar from Istituto di Clinica Medica IV, Universita degli Studi di Firenze, Florence, Italy

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinzani, M., Zipser, R.D. The hepatorenal syndrome. Intensive Care Med 13, 148–153 (1987). https://doi.org/10.1007/BF00254697

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254697

Keywords

Navigation